Cat. No. Name Size Price Add Cart
KI2010SCH-5271235 mg$686.4
SCH-52712310 mg$943.8
SCH-52712350 mg$2745.6
SCH-527123200 mg$6292

Chemical Characteristic

Product NameSCH-527123
SynonymsN/A
CAS No.473727-83-2
Molecular Weight 397.42
FormulaC21H23N3O5
Chemical Name3-((3-((dimethylamino)carbonyl)-2-hydroxyphenyl)amino)-4-(((r)-1-(5-methylfuran-2-yl)propyl)amino)cyclobut-3-ene-1,2-dione
SmilesC(=O)(c1c(c(ccc1)NC1=C(C(=O)C1=O)NC(CC)c1oc(cc1)C)O)N(C)C
Chemical Structure

Biological activities

SCH-527123 is a novel antagonist of both CXCR1 and CXCR2 with IC50s of 36 and 2.6 nM, respectively.[1] It binds with high affinity to the CXCR2 receptors of mouse, rat, and cynomolgus monkey with Kd values of 0.20, 0.20, and 0.08 nM, respectively. SCH-527123 also potently inhibits CXCR2-mediated chemotaxis with an IC50 of approximately 3-6 nM, and weakly inhibits cynomolgus CXCR1-mediated chemotaxis with an IC50 of approximately 1 μM. In vivo, oral administration of SCH-527123 prevents pulmonary neutrophilia (ED50 = 1.2 mg/kg) and goblet cell hyperplasia (32-38% inhibition at 1-3 mg/kg) in mice following the intranasal lipopolysaccharide (LPS) administration. In rats, oral administration of SCH-527123 also suppresses the pulmonary neutrophilia (ED50 = 1.8 mg/kg) and increase in bronchoalveolar lavage (BAL) mucin content (ED50 ≤0.1 mg/kg) induced by intratracheal (i.t.) LPS.[2] Moreover, SCH-527123 treatment significantly decreases tumor growth and microvessel density in colorectal cancer xenografts models in vivo.[3]

Protocols

In vivo: Prior to use, SCH-527123 is dissolved in 10 ml of 20% HPβCD by sonication.[4]

References

[1] Dwyer MP, et al. Discovery of 3,4-diaminocyclobut-3-ene-1,2-dione-based CXCR2 receptor antagonists for the treatment of inflammatory disorders. Curr Top Med Chem. 2010, 10(13): 1339-1350.
[2] Chapman RW, et al. A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation. J Pharmacol Exp Ther. 2007, 322(2): 486-493.
[3] Ning Y, et al. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models. Mol Cancer Ther. 2012, 11(6): 1353-1364.
[4] Varney ML, et al. Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases. Cancer Lett. 2011, 300(2): 180-188.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.